}

Arab Pharmaceuticals’ Q1 FY2026/27 profits shrink 54% YoY

Updated 11/1/2026 3:25:00 PM
Arab Pharmaceuticals’ Q1 FY2026/27 profits shrink 54% YoY

Arab Finance: Arab Pharmaceuticals Company registered a net profit after tax of EGP 28.222 million in the first quarter (Q1) of fiscal year (FY) 2026/2027, as per the unaudited financial results.

The profits registered in the three-month period that ended on September 30, 2026, dropped by 54% year-on-year (YoY) from EGP 62.016 million.  

Basic earnings per share (EPS) fell to EGP 2.09 from EGP 4.53, while sales increased by 7% to EGP 328.673 million from EGP 306.024 million.

During FY 2025/26, the company’s net profits climbed by 16% YoY to EGP 263.594 million from EGP 227.858 million.

Related News